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Abstract
We develop a novel nanohybrid showing a strong antibacterial activity on all of the tested pathogens, including methicillin-
resistant Staphylococcus auerus and silver-resistant E. coli. The nanohybrid consists of silver nanoparticles (AgNPs) supported
on 1 nm-thick silicate platelets (NSPs). The AgNP/NSP nanohybrid enables to encapsulate bacteria and triggers death signals
from the cell membrane. The geographic shape of the NSPs concentrates AgNPs but impedes their penetration into
attached cells, mitigating the detrimental effect of silver ion deposition in applied tissues. Moreover, the tightly tethered
AgNPs on NSP surface achieve a stronger biocidal effect than silver nitrate, but bypassing Ag
+ mechanism, on silver-resistant
bacteria. This nanohybrid presents an effective and safe antimicrobial agent in a new perspective.
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Introduction
Soluble silver ion species are extensively used as antiseptics for
controlling burn and eye infections. Silver ions can disrupt the
bacterial cell wall, penetrate the cell and interfere with the
physiological function of cell respiration and metabolites via
binding to the thiol groups present in proteins [1,2]. However, the
frequent use of silver-ion agents has caused the appearance of
notable silver resistant bacteria in hospitals, an emerging threat to
public health [3,4]. Similar to the mechanism of most heavy metal
resistance systems, silver resistance is mediated by a plasmid- or
chromosome-encoded Ag
+ efflux pump [5]. Horizontal spreading
of the plasmid can enhance the bacterial pathogenesis and
resistance to antibiotics [3]. Hence, finding new antimicrobial
agents and understanding the mechanism for inhibiting the silver-
resistant bacteria are urgent research tasks.
Recent advances in nanotechnology have led the discovery of
nanoscale inorganic materials that exhibit control over bacterial
growth, such as silver-doped titanium oxide and silver nanopar-
ticles (AgNPs) [6,7,8,9]. However, the antimicrobial mechanism
of AgNPs is not well clarified. Dissolved Ag
+, material-cell contact
and internalization of the nanoparticles could contribute to
bacterial cell death [9,10]. Although most studies [8,11,12]
emphasize the importance of dissolved Ag
+ on the antibacterial
effect, several reports [13,14,15] claim that leaching Ag
+ only
cannot account for the AgNP cytotoxicity. In addition, the size
and morphology of the nanoparticles also affect the biocidal
performance [16,17,18]. Moreover, recent studies [19,20,21] and
our previous report [22] suggest that the biocidal effectiveness of
AgNPs primarily depends on the membrane disruption at the
cell-material contacting surface, while the soluble Ag
+ species
leaching from AgNP is not the main thrust to the cytotoxicity.
Based on the Ag
+-independent bactericidal mechanism, AgNPs
are considered to be effective for inhibiting silver-resistant
bacteria. However, recent studies [16,23,24] revealed that pure
AgNPs were ineffective at controlling silver-resistant bacteria,
possibly because of the inherent tendency of AgNP agglomeration
into Ag clusters and the consequent decrease in the particle/cell
surface interaction.
To provide well-dispersed AgNPs in solution, a method of
fabricating novel nanohybrids consisting of AgNPs immobilized on
the surface of nanoscale silicate platelets (NSPs) was established.
The high aspect-ratio NSPs were derived from layered silicate clay
and in irregular polygonal shapes with an average platelet
dimension of 8068061,100610061n m
3 [25,26]. NSP provides
an extensive reacting surface for the formation of spherical AgNPs,
synthesized by the in situ reduction of silver nitrate with methanol.
Without any conventional organic stabilizers or sodium borohy-
dride reducing agents, the naked silver nanoparticles were organic-
free and fully reduced from Ag
+ with a colloidal stability in water.
This nanohybrid was examined for its efficacy in inhibiting the
growth of both silver-sensitive and silver-resistant bacteria. The
cell-surface interaction with the nanohybrid and the possible
biocidal mechanism was also investigated.
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Synthesis of AgNP/NSP nanohybrid
The in situ reduction of silver nitrate in the presence of the
silicate clay generated AgNP/NSP hybrids. The NSP material was
prepared by exfoliating the Na
+-MMT silicate clay, which
involved the ionic exchange of the clay with a polyamine-salt
exfoliating agent to randomize the layered structure [25]. The
NSP material was characterized to have a fully exposed surface in
comparison with that of the pristine MMT clay. The polyamine-
salt was removed from the NSPs through a toluene and aqueous
sodium hydroxide bi-phasic extraction. A single NSP possesses ca.
12,000,20,000 ions at the dimension of 80680,1006100 nm
2
(described in Materials and Methods). The 1-nm thick platelet
shape of an NSP with a sodium ion at the cationic exchange
capacity (CEC) of 1.2 mequiv/g [27] has a large surface area for
associating silver nitrate and AgNP formation, following the
methanol reduction (Fig. 1A).
After the 2 hr reduction of silver nitrate by methanol, small
nanoparticles appeared on the NSP surface (Fig. 1B) when an
equal molar ratio of Ag
+ and CEC or the weight ratio of Ag
+ to
NSP of 7/93 was used (Fig. 1C). The stable AgNPs on NSP were
generated after a 4 hr reduction and showed spherical shape with
a 6.662.7 nm diameter, estimated from 200 AgNPs in Fig. 1D.
The AgNPs were fully reduced from silver nitrate and colloidal
stable in water, evidenced by the UV absorption at 414 nm
(Fig. 1E). UV-Vis result revealed a reduced intensity of UV
absorbance and a slightly shifted surface plasmon to a longer
wavelength after 50 min reaction (Fig. 1E), potentially due to the
enlarged particle size over 3.5 nm [28]. This phenomenon is also
observed for the fabricated AgNPs with other clay, such as
montmorillonite [19] or laponite [29].
Further tests on the dissolved Ag
+ in solution showed only
356 ppb in 1.0 wt% AgNP/NSP solution. Adding nitric acid to
convert the free Ag
0 to Ag
+ in solution resulted in the similar
concentration of silver ion (395 ppb) by ICP-MS analysis,
indicating that very few Ag
0 particles shell off the NSP carrier.
Because the nanohybrid was prepared without using any organic
dispersant, the generated AgNP was considered to be naked
surface and free of organic wrapping. These results demonstrate
that the NSP is a suitable dispersing agent to fabricate fine
inorganic nanoparticles.
Antimicrobial activity of AgNP/NSP
The close-up images of AgNP/NSP-coated E. coli under FE-
SEM (Fig. 2A and 2B) and TEM (Fig. 2C) revealed that all the
observed NSP wrapped the bacteria and no AgNP is found in the
cell body of E. coli (n=595) (Fig. 2C). In contrast, when the
bacteria were treated with 120 mM free AgNPs for 4 hr (Fig. 2D),
AgNPs was found on the membrane or in the cells of E. coli (20%
of counted cells, n=1728). These observations suggest that the
high electrostatic affinity of NSP may facilitate high adherence
onto the bacterial surface and facilitate AgNP-cell interaction,
causing local membrane damage (illustrated in Fig. 2E). The
antibacterial potency was evaluated and compared to our previous
findings for AgNP/Clay [22]. While treating Salmonella typhimurium
with 0.01 wt% AgNP/NSP (7/93 by weight ratio) for 4 hr, the
apparent clustering of bacteria was observed. This clustering was
potentially caused by bridging the bacteria through the nanohy-
brid (Fig. 3A and 3B). Most applied nanohybrid attached to and
encapsulated the surface of bacteria (Fig. 3C, the arrow). At a
higher dosage of AgNP/NSP (0.1 wt%), Staphylococcus aureus were
wrapped with the nanohybrids (Fig. 3E and 3F), but none of the
bacterial membrane was found to be penetrated by the platelets.
These observations suggest that most nanohybrids have intensive
attracting forces to adhere on surface, which might interfere with
the bacterial growth through a physical trapping mechanism. To
determine the effectiveness of the biocidal activity, 1610
5 bacterial
cells, such as the Salmonella (Gram negative) and Staphylococcus
(Gram positive), were plated on the AgNP/NSP-containing LB
agar. To determine the minimal inhibitory concentration (MIC),
the complete inhibition of cell growth of tested bacterial strains
was achieved at 0.02 wt% AgNP/NSP (Fig. 3G and 3H). These
results were an improvement over the previous report using
AgNP/Clay, in which 0.05 wt% material was required [22]. Here,
the difference between the high aspect-ratio NSP and the pristine
layered clay for the bacterial surface interaction is noteworthy.
Particularly, as the wild type S. aureus and the antibiotic-resistant
MRSA showed the same vulnerability to the nanohybrid (Fig. 3I),
other infectious pathogen, such as Escherichia coli, all showed
complete inhibition on the 0.02 wt% AgNP/NSP-containing agar
(Fig. 4A). The antibacterial performance of the nanohybrid
illustrates the highly potent and general biocidal activity on all
tested bacteria through the mechanism of physical adhesion to the
bacterial cell.
Antimicrobial mechanism of AgNP/NSP and Ag
+
To discriminate the individual roles of NSP and AgNP on
inhibiting bacterial growth, both NSP and AgNP/NSP were
investigated for their antibacterial potencies on LB agar. We found
that the growth of E. coli was significantly inhibited by the AgNP/
NSP (Fig. 4A), but not NSP (Fig. 4B), indicating that the AgNP is
the predominant factor governing antibacterial activity. The
integrity of the cell membrane was first explored to understand
the biocidal effect of the AgNP/NSP by determining the release of
intracellular b-galactosidase, an indicator for the inner membrane
leakage of bacteria [30]. After incubating with 0.01 wt% or 0.02
wt% AgNP/NSP, E. coli ML35p released a significant amount of
intracellular b-galactosidase into the culture medium during the
first 2 hr reaction (p,0.05 in both, Fig. 4D). The highest
extracellular enzyme activity was detected after the 8 hr post-
treatment and then the activity gradually declined. Notably, the
treatment with 0.02 wt% NSP alone also resulted in moderate
damage of the bacterial membrane at 4 hr and 8 hr in reference to
the untreated control (p,0.05, Fig. 4E).
The membrane disruption could decrease the cell polarity and
allow the retention of DiBAC4(3), a lipophilic anionic fluorophore
and a quantitative indicator for the loss of transmembrane
potential [31]. Treating E. coli with AgNP/NSP had resulted in
a dose-dependent increased in the fraction of DiBAC4(3)
+ cells
(Fig. 4G). At 0.05 wt% and 0.02 wt% of nanohybrid, there was a
conversion of 78.062.8% and 50.463.3% cells into DiBAC4(3)
+
after a 4 hr incubation, respectively (p,0.05 in both). By
comparison, treating with 0.05 wt% and 0.02 wt% NSPs alone
triggered 48.467.6% (p,0.05) and 18.560.7% fluorescent cells
observed, respectively (Fig. 4H). Taken together, these results
demonstrated that treating AgNP/NSP with bacteria severely
disrupts the inner membrane integrity (Fig. 4D and 4G). The
support material of NSP has a low antimicrobial effect (Fig. 4B)
but can trigger a transient and reversible disturbance of membrane
permeability (Fig. 4E and 4H), which is potentially caused by the
disorder of the lipopolysaccharide structure or loss of function of
the outer membrane proteins on the encountered surface [32,33].
The antibacterial mechanism involving the Ag
+ was investigat-
ed, in order to compare with the above findings using the
nanohybrids. The complete growth inhibition of E. coli was
observed at a concentration of 120 mM silver nitrate, comparable
to the potency of 0.02 wt% AgNP/NSP (containing 129.8 mM
AgNP/NSP on Silver-Resistant Bacteria
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NSP and Ag
+ exhibited a similar MIC and biocidal activity on E.
coli at the same silver concentration. Notably, upon treatment of
Ag
+ no b-galactosidase activity was detected using the membrane
permeability assay (Fig. 4F), perhaps because of the rapid enzyme
inactivation by silver nitrate in solution. However, Ag
+ indeed
caused the membrane damage and loss of transmembrane
potential, evidenced by the intracellular staining of ionic voltage-
sensitive DiBAC4(3) (Fig. 4I). Unexpectedly, the doses of 60, 120
and 300 mM silver nitrate all steered 50–60% DiBAC4(3)
+ cells
(Fig. 4I), distinctly different from the time and dose-dependent
results obtained when using AgNP/NSP (Fig. 4G).
Experimental evidence of the complete reduction of Ag
+ to Ag
0
in the synthesis and low dissolvability of the AgNPs in solution
suggested that the cytotoxicity of the nanohybrid may not be
caused by the released Ag
+. Furthermore, the supernatant of 1
wt% AgNP/NSP had shown no antibacterial activity even for the
sample that had undergone a six-month period of storage. In
Figure 1. Monodispersed silver nanoparticles on NSPs. AgNP/NSP, synthesized at the equivalent ratio of Ag/CEC=1.0, was fabricated by
methanol reduction at 80uC. Diagram of the synthesis of the nanohybrid is illustrated (A). The surface structure of the AgNP/NSP was revealed by the
FE-SEM (B-D). The absorbance at 420 nm kinetically revealed the reduced status of the AgNPs at the indicated times after methanol reduction (E).
doi:10.1371/journal.pone.0021125.g001
AgNP/NSP on Silver-Resistant Bacteria
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supernatant of AgNP/NSP-treated cells (Fig. 4D). These results
strongly indicated that the cytotoxicity of the AgNP/NSP was
mainly dependent on the concentrated AgNPs on the NSP carrier,
rather than on the soluble Ag
+ species or free AgNPs in solution.
Severe membrane disruption may affect the nutrient uptake,
electronic transport and ROS production. By feeding E. coli with a
fluorescein-labelled glucose analog, 2-NBDG, almost all bacteria
became green fluorescent (Fig. 5A). FACS analysis showed that the
glucose uptake was dramatically impaired in AgNP/NSP-treated
E. coli (36%) after the 4 hr incubation in comparison to those in
nanomaterials-untreated control (96%) and NSP-treated cells
(79%) (Fig. 5A). In addition, the intracellular ATP content was
also significantly reduced in a dose-dependent manner at 4 hr
post-treatment in AgNP/NSP-treated E. coli, compared to that of
NSP-treated cells (Fig. 5B). Using the H2DCF staining and FACS
analysis, robust ROS production was confirmed in 36.069.9%
and 69.363.3% of the cells during the 4 hr incubation in which E.
coli were treated with 0.02 wt% and 0.05 wt% nanohybrids,
respectively (p,0.05 in both). In contrast, 0.05 wt% NSPs steered
only a limited amount of DCF
+ cells (7.060.8%, Fig. 5C).
Furthermore, the pretreatment of ROS scavengers, such as lipid
peroxidation inhibitor U83836E and a superoxide dismutase
mimetic Tempol, limited the AgNP/NSP-steered ROS production
(Fig. 5C). Glutathione, a well-known cellular anti-oxidant [34],
successfully rescued the AgNP/NSP-induced cell death (Fig. 5D
and Fig. S1), demonstrating the critical role of ROS in this
biocidal pathway. These results emphasize that the AgNP/NSP
nanohybrid, but not NSP alone, constitutively disrupts the
integrity of membrane, impedes the nutrient uptake and produces
detrimental free radicals on the encountered cells.
Effectiveness of AgNP/NSP on silver-resistant bacteria
The introduction of NSP facilitates the cell-material interaction
and provides a novel antimicrobial activity of AgNP/NSP,
bypassing the Ag
+-mediated intracellular protein/DNA denatur-
ation. This unique biocidal property was further tested on bacteria
with Ag
+-resistance, which can be obtained by transfoming a
pMG101 plasmid. Plasmid-free, parental E. coli J53 was silver-
sensitive and showed complete growth inhibition on LB agar
containing 120 mM silver nitrate or 0.02 wt% AgNP/NSP
(Fig. 6A). Plasmid-transformed, silver-resistant J53/pMG101
rendered a 19.266.3% survival rate under 120 mM silver nitrate
and yet 2.863.1% of the cells were detected even upon raising the
silver concentration to 600 mM (MIC.600 mM). Compared to the
120 mM silver nitrate, 0.02 wt% AgNP/NSP (containing
129.8 mM silver) rendered only 5.964.0% surviving cells,
indicating a significantly improved antimicrobial effect (student t
test, p,0.05, Fig. 6B). In addition, the application of 0.1 wt%
nanohybrids (containing 648.9 mM silver) completely blocked the
growth of J53/pMG101, demonstrating the effectiveness of the
AgNP/NSP on controlling silver-resistant bacteria (Fig. 6B).
Assuming that the difference between J53 and J53/pMG101
bacteria is only in the Ag
+ channel system, both silver-sensitive and
silver-resistant bacteria should have responded with the same
sensitivity to AgNP/NSP. However, efficient controlling the
growth of E. Coli J53/pMG101 required 0.1 wt% nanohybrid,
which was five fold the dosage of the MIC in parental E. Coli J53.
The higher MIC of the nanohybrid on E. Coli J53/pMG101 may
be caused by elevated cellular antioxidant factors, deficiency of
death-signal mediators or attenuated attacks on the membrane. To
clarify these possibilities, the ratios of PI
+- (Fig. 6C) and ROS-
producing cells (Fig. 6D), reduction levels of intracellular ATP
(Fig. 6E) and glucose uptake (Fig. 6F) were measured. These
biochemical analyses all failed to show a significant difference in
the AgNP/NSP-treated J53 and J53/pMG101 cells, indicating
that the nature of the electrostatic affinity and attacking strength of
the nanohybrid were conserved for both E. coli strains. In addition,
producing intracellular ROS was also valid in silver-resistant
strains (Fig. 6D), suggesting the propagation of AgNP/NSP-
Figure 2. Material distribution in AgNP/NSP-treated E. coli. The E. coli were treated with 0.1 wt% AgNP/NSP (A, B, C) or free AgNPs (D) alone
for 4 hr. The cell-nanomaterial complexes were examined using FE-SEM (A, B) and TEM (C, D). AgNP alone is used as a positive control for the
nanomaterial accumulation in cells (D). Representive Diagram of the nanohybrid-bacteria interaction is illustrated (E). LPS, lipopolysaccharide, OM,
outer membrane, IM, inner membrane.
doi:10.1371/journal.pone.0021125.g002
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rescue assay (Fig. 5D and Fig. S1) and the results shown in Fig. 6,
overexpressed intracellular antioxidants in J53/pMG101 could
account for the five fold MIC requirement of the nanohybrid to
achieve complete growth inhibition of the silver-resistant bacteria.
Discussion
We report the synthesis of homogenously dispersed AgNPs on
silicate platelets without organic wrapping on the particle surface.
The inorganic clay platelets served as a carrier for stabilizing the
AgNPs without the inherent agglomeration by overcoming the
ionic or van der Waals attraction among the nanoparticles.
Compared to the six layers of stacked clay in our previous report
[22], single-layered NSPs are fully exfoliated and show a higher
CEC and full exposure of ionic charges. These characteristics
enable the formation of smaller AgNPs (7 nm vs. 26 nm diameter
of AgNP) and provide more cell-material contact surface, possibly
accounting for the improved antibacterial effectiveness of this new
nanohybrid.
Although high electrostatic activity of NSP can transiently
disturb the cellular membrane integrity and cause a moderate
alteration on the membrane permeability, NSP alone did not show
significant biocidal activity in LB medium. Moreover, in contrast
Figure 3. Material-cell interaction and antimicrobial activity of AgNP/NSP. Salmonella typhimurium (A–CD) and Staphylococcus aureus (D–
FG) were treated with 0.01 wt% (B, C) and 0.1 wt% AgNP/NSP (E, F), respectively, for 6 hr at 37uC. The cell-nanomaterial complexes were examined
using FE-SEM at 80 kV. The arrow indicates the nanohybrid-encapsulated bacteria (C). S. typhimurium (G), S. aureus (H) and methicillin-resistant
S. aureus (MRSA) (I) were cultured on AgNP/NSP-containing LB agar and the growth inhibition was estimated by the colony formation at 14–16 hr at
37uC. *, p-values,0.05, Student’s t-test.
doi:10.1371/journal.pone.0021125.g003
AgNP/NSP on Silver-Resistant Bacteria
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dramatically decreased glucose uptake and ATP synthesis, and
robust detrimental ROS production. These biochemical analyses
emphasize that AgNP is the main thrust of AgNP/NSP, but not
NSP, in bacterial interaction and microbial growth.
Enhancing the antimicrobial activity and reducing the nano-
toxicity to mammalian cells will advance the clinical application of
nanoparticles in medicine. Our newly synthesized AgNP/NSP
exhibited a general and effective biocidal activity to all of the tested
Gram-positive and Gram-negative bacteria herein, including
MRSA. Notably, the silicate platelet NSP has shown none of
obvious pathology in eukaryotes and rodents [25]. In addition, the
nanohybrid contains very low concentrations of free Ag
+ and
AgNPs leaching from the nanohybrids. The geometric shape of
high aspect-ratio NSP also impedes the penetration of immobilized
AgNPs into mammalian cells. These characteristics help the
applied nanohybrids to avoid deposition of detrimental silver in
the body, illustrating the safety advantage of nanohybrid for
clinical applications.
The newly developed nanohybrid exhibited general antibacte-
rial activity, and stronger potency than silver ions, in controlling
silver-resistant bacteria. The mechanistic understanding of the
thrust of nanomaterials will bring forth the promise for efficient
control of emerging public-threat pathogens.
Materials and Methods
Materials preparation of NSPs and AgNP/NSP
NSPs are prepared from a Na
+ form of layered smectite clay,
montmorillonite (Na
+-MMT, from Nanocor), according to the
exfoliation process reported previously [25]. The total surface area
of 1 g Na
+-MMT is about 750 m
2/g [35]. The CEC is 1.2 meq/g
[27], which is equivalent to 7.2610
20 monovalant cations per
gram of MMT (CEC6Avogadro’s number 6.02610
23). The
Figure 4. Disrupted membrane permeability and polarity by AgNP/NSP. Approximately 1610
5 E coli DH5a and ML35p strains were spread
on NSP (A), AgNP/NSP (B) or silver nitrate (C) containing LB agars, where nanohybrid materials were mixed with at the indicated concentrations.
These colonies were counted after overnight incubation at 37uC. After treating E. coli ML35p with the nanomaterials (D, E) or silver nitrate (F) in LB
broth, the activity of the released intracellular b-galactosidase in the supernatant was kinetically determined by reacting with ONPG and
quantitatively measured with spectrophotometry at 420 nm. The number of fluorescent DiBAC4(3)
+ cells in NSP- (G), AgNP/NSP- (H) or silver nitrate-
(I) treated E. coli DH5a were determined by FACS analysis.
doi:10.1371/journal.pone.0021125.g004
AgNP/NSP on Silver-Resistant Bacteria
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(750610
18 nm
2/g)/(1.2 meq/g66.02610
23)=1.03 nm
2/ion. The
surface area of each NSP is 80680 to 1006100 nm
2 [25,26].
Therefore, both sides of NSP layer contain 12,427 (8068062/
1.03),19,420 (100610062/1.03) cations approximately.
The procedures for preparing the AgNP/NSP nanohybrid are
described in the following sentences. NSPs (0.3 g in 30 g water;
1.0 wt%) were dispersed in deionized water at 80uC and
mechanically stirred for several hours, followed by the addition
of an AgNO3 solution (0.061 g of 1.0 wt% in water) at an equal
molar ratio of Ag
+ to cationic exchange capacity (CEC). The
process involved the replacement of Ag
+ with Na
+ counter ions on
the clay surface and, consequently, reduction of the Ag
+ by
ethanol (18.05 ml). The reaction mixture was stirred vigorously
and monitored by observing the color change from yellow to deep-
red, indicating the reduction of Ag
+ to Ag
0. The UV absorption at
414 nm indicates the formation of Ag nanoparticles. The particle
sizes were measured by field emission scanning electronic
microscopy (FE-SEM, Zeiss EM 902A) at 80 kV. The size
distribution was measured from an average of 100 individual
particles.
The concentration of dissolved Ag
+ in solution was determined
by inductively coupled plasma mass spectrometry (ICP-MS, PE-
SCIEX ELAN 6100 DRC). The supernatant of a 1.0 wt% AgNP/
NSP in solution was collected after centrifugation at 16,0006g for
30 min. The ICP-MS analysis showed that the Ag
+ concentration
was 356 ppb. After adding 3% HNO3 to the supernatant to
convert the free Ag
0 to Ag
+, the concentration changed to
395 ppb.
Sources of bacteria
Escherichia coli (E. coli) strains DH5a, ML35, J53 and
J53pMG101 were grown at 37uC and maintained on Luria-
Bertani (LB) agar. The ML35 strain was obtained from the
Figure 5. The biocidal pathway in AgNP/NSP treated cells. E. coli were cultured with NSPs or AgNP/NSP for 4 hr and subjected to biochemical
analysis. The glucose uptake (A), ATP production (B) and intracellular ROS production (C) were determined by the incorporation of 2-NDBG, the
luciferase-luciferin reaction and the H2DCF-DCF conversion, respectively. Ratios of 2-NDBG
+ and DCF
+ cells were determined by FACS analysis. For the
ROS test, 1% H2O2 was used as positive control. U83836E, 50 mM. Tempol, 50 mM. Before the seeding of E. coli,5 0ml glutathione (10 mM) was applied
on the AgNP/Clay containing agar plates (D). The number of bacterial colonies was counted and these data were obtained from three independent
results. *, p-values,0.05, Student’s t-test.
doi:10.1371/journal.pone.0021125.g005
AgNP/NSP on Silver-Resistant Bacteria
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The J53 and J53/pMG101 stains were kindly provided by Prof.
Chi-Ming Che at the University of Hong Kong and Prof. Anne
Summers at the University of Georgia, USA. Staphylococcus aureus
(S. aureus), including methicillin-resistant S. aureus (MRSA), were
isolated from Taichung Veteran General Hospital. Salmonella
typhimurium was provided from the Animal Technology Institute of
Taiwan. Handling of the potentially hazardous bacteria, especially
the MRSA and J53/pMG101 strains, was performed strictly
according to the standard biosafety procedures of National Chung
Hsing University.
Bactericidal effect of nanomaterials
The bacteria were synchronized at the log phase of the growth
curve (OD600 0.4,0.6; ,10
9 cfu/ml), and an aliquot of log-phase
cells (,10
5 cells) were then reacted with nanomaterials in LB
broth or on LB agar. The reduction of bacterial growth and the
minimal inhibitory concentration (MIC) were determined by the
number of colonies after an overnight incubation on LB agar at
37uC. The colony number of untreated cells is set as 100%.
Evaluation of inner membrane permeability
E. coli ML35p, a pUC19 plasmid-transformed ML35 strain, is
generally used for investigating cell membrane permeability
because of its high expression levels of intracellular b-galactosidase
and lack of lactose permease [30]. The cells were incubated to log-
phase growth (OD600 0.4–0.6) at 37uC with 1 mM isopropyl b-D-
1-thiogalactopyranoside (IPTG), an allolactose analog, to induce
the synthesis of the pUC19-encoded b-galactosidase. Cells were
washed and resuspended in the inner membrane wash buffer
(10 mM NaH2PO4, 0.1 M NaCl) before reacting with the testing
nanomaterials. For the time-interval experiments, the reaction of
bacteria with materials was set at 4uC in LB broth to provide a
consistent cell number. At indicated times, the cells and materials
were centrifuged at 3,0006g and the supernatants were collected
and reacted with ortho-nitrophenyl-b-galactoside (ONPG) for
10 min, which provides a colorimetric index of the b-galactosidase
activity. The samples were measured spectrophotometry at
420 nm (Paradigm, Beckman-Coulter).
Alteration of bacterial membrane potential
DiBAC4(3) (Invitrogen, USA) was used as an indicator in the
change of membrane potential [31]. After the reaction, the treated
cells were labeled with DiBAC4(3) (10 mg/ml) for 30 min at room
temperature. The quantitative measurement of DiBAC4(3)
+ cells
was determined by flow cytometry (FACScan, Becton-Dickinson).
Glucose uptake assay
A cell-impermeable, fluorescent glucose analog, 2-NDBG (2-(N-
(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)amino)-2-deoxyglucose), was
used to determine the nutrient uptake efficiency of the bacteria
[36]. Cells in log-phase of growth (OD600 0.4–0.6) were incubated
with the testing material for 4 hr in LB broth. The cells were
centrifuged and resuspended in a 2-NDBG (100 mM) phosphate
Figure 6. Inhibition of silver-resistant bacteria by AgNP/NSP. The cytotoxicity of silver nitrate and AgNP/NSP on E. coli J53 (A) or J53/pMG101
(B) were tested by colony growth on agar. Silver concentrations for 0.01, 0.02, 0.05 and 0.1 wt% AgNP/NSP were 64.9 mM, 129.8 mM, 324.5 mM and
648.9 mM, respectively. At 4 hr incubation with the nanomaterials, the ratios of fluorescent PI/Syto9 cells (C), DCF
+ cells (D) and 2-NDBG
+ cells (E) were
determined by FACS analysis. The content of intracellular ATP was reflected by luciferase activity in the treated cells (F). The data represent triplicate
(A, B) or duplicate experimental results (C–F). *, p-values,0.05, Student’s t-test.
doi:10.1371/journal.pone.0021125.g006
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of 2-NDBG
+ cells was performed using flow cytometry (FACScan,
Becton-Dickinson).
Intracellular ATP determination
The intracellular ATP content was measured by the ATP
determination kit (Molecular Probes, USA). Cells in log-phase
growth were treated with the nanomaterials in 50 mM HEPES
buffer (pH 7.0) containing 5 mM glucose at room temperature for
4 hr. The cells were lysed with 1% trichloroacetic acid in the
presence of 2 mM EDTA. After a 30-min incubation at 4uC, the
samples were neutralized with two volumes of 0.1 M Tris acetate
(pH 7.8). The cell aliquots (5 ml each) were added to luciferase-
luciferin reaction buffer (95 ml) in 96-well plates and their ATP
contents were reflected by the intensity of luminescence (Para-
digm, Beckman-Coulter). The exact amount of ATP in the
experimental samples was calculated from the established standard
curve.
ROS detection and free radicals blocking assay
The bacteria in log-phase growth were treated with the
nanomaterials for 4 hr in LB medium and then reacted with an
intracellular ROS indicator, H2DCFDA (50 mM, 29,-79-dichloro-
fluorescin diacetate, Invitrogen) for 30 min at room temperature
[22]. The quantitative evaluation of the ROS-producing cells was
determined by flow cytometry (FACScan, Becton-Dickinson). Two
ROS inhibitors, U83836E (50 mM, Tocris) and Tempol (50 mM,
Tocris), were used to pretreat the E. coli for 1 hr before the cell-
materials reaction. The Tempol/U83836E antioxidants were
removed before the attack of AgNP/NSP. In a glutathione-
rescued survival assay, glutathione (50 ml, 10 mM) was applied on
a LB agar plate and then approximately 1610
5 cells were seeded
onto the plates. After a 14 hr incubation at 37uC, colony
formation units were manually counted.
Statistical analysis
Each experiment was replicated two or three times and the data
are presented as mean 6 SEM (standard error of mean). A
statistical analysis of the data was performed using Microsoft
Excel. Differences were analyzed with Student’s t-test and
considered significant at p-values,0.05.
Supporting Information
Figure S1 Growth rescue by the glutathione pretreatment for
the AgNP/NSP-coated E. coli. The E.coli were first reacted with
200 mM glutathione for 1 hr at room temperature. The cells were
concentrated by centrifuge at 13,000 rpm for 5 min and
resupended in PBS containing 0.02 wt% AgNP/NSP for 4 hr.
The cell surviving rate is estimated by the number of cell colonies
on LB agar plates after 14 hr incubation at 37uC. *, p-
values,0.05, Student’s t-test.
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